INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Avery Products Corporation Data Breach

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Avery Products Corporation recently disclosed that it suffered a data breach that compromised the sensitive personal data of thousands of individuals. This data breach has led to concerns over the security of sensitivepersonal information entrusted to Avery. WHAT’S THIS ABOUT? On December 9, 2024, […]

Levi & Korsinsky, LLP Investigates Northeast Rehabilitation Hospital Network Data Breach

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Northeast Rehabilitation Hospital Network recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to NRHN. WHAT’S

Levi & Korsinsky, LLP Investigates Formula One Digital Media Limited VPPA Violation

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky, LLP is investigating potential claims on behalf of individuals who have subscribed to Formula One’s Website (https://www.formula1.com/) and watched pre-recorded video content through the FormulaOne website. Levi & Korsinsky, LLP’s investigation indicates that legally protected data may have been unlawfully intercepted

Investors in Sun Communities, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SUI

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Sun Communities, Inc. (NYSE:SUI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sun-communities-inc-lawsuit-submission-form?prid=124142&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky, LLP Investigates Pacific Pulmonary Medical Group Data Breach

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Pacific Pulmonary Medical Group recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to PPMG. WHAT’S

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Rentokil Lawsuit – RTO

NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=124156&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Shareholders that lost money on Joint Stock Company Kaspi.kz (KSPI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=124141&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

BayMark Health Services, Inc. Data Breach under Investigation by Levi & Korsinsky, LLP

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / BayMark Health Services, Inc. recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to BayMark.

Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – REGN

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124143&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top